References
- Ramoska E A, Spiller H A, Winter M, Borys D. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med 1993; 22: 196–200
- Erickson F C, Ling L J, Grande G A, Anderson D L. Diltiazem overdose: case report and review. J Emerg Med 1991; 9: 357–366
- Ferner R E, Odemuyiwa O, Field A B, Walker S, Volans G N, Bateman D N. Pharmacokinetics and toxic effects of diltiazem in massive overdoses. Hum Toxicol 1989; 8: 497–499
- Roper T A, Sykes R, Gray C. Fatal diltiazem overdose: report of four cases and review of the literature. Postgrad Med J 1993; 69: 474–476
- Rey J L, Lecuyer D, Bernasconi P, Quiret J C. Voluntary diltiazem poisoning with sinus failure and atrio-ventricular block. Presse Med 1983; 12: 1873–1874
- Humbert VH, Jr, Munn N J, Hawkins R F. Non-cardiogenic pulmonary edema complicating massive diltiazem overdose. Chest 1991; 99: 258–259
- Quezado Z, Lippmann M, Wertheimer J. Severe cardiac, respiratory and metabolic complications of massive verapamil overdose. Crit Care Med 1991; 19: 436–438
- Fang C C, Tsai L M. Hematologic complications of diltiazem overdose. Am Heart J 1993; 126: 1017–1018
- Wax P M. Intestinal infarction due to nifedipine overdose. 5th World Congress of the World Federation of Associations of Clinical Toxicology Centers & Poison Control Centers. Taipei, Taiwan, November 8-11, 1994; 200, (Abstract)
- Lamaison D, Abrieu V, Fialip J, Dumas R, Andronikoff M, Lavarenne J. Acute intestinal occlusion and calcium antagonists. Therapie 1989; 44: 201–202
- Schultz H S, Vernon B. Intestinal pseudo-obstruction related to using verapamil. West J Med 1989; 151: 556–558
- Sporer K A, Manning J J. Massive ingestion of sustained-release verapamil with a concretion and bowel infarction. Ann Emerg Med 1993; 22: 603–605
- Zinner M J, Sherlock D, Ferrara A, McFadden D, Wait R B, Jaffe B M. Verapamil inhibition of the intestinal effects of substance P. Surgery 1985; 98: 230–235
- Maggi C A, Grimaldi G, Meli A. The effects of nifedipine and verapamil on high K+ induced contractions of the rat intestinal tract in vivo. Jap J Pharmacol 1983; 33: 335–341
- Chaffman M, Brogden R N. Diltiazem. A review of its pharmacological properties and therapeutic efficacy. Drugs 1985; 29: 387–454
- Schoffstall J M, Spivey W H, Gambone L M, Shaw R P, Sit S P. Effects of calcium channel blocker overdose-induced toxicity in the conscious dog. Ann Emerg Med 1991; 20: 1104–1108
- Walus K M, Fondacaro J D, Jacobson E D. Effects of calcium and its antagonists on the canine mesenteric circulation. Circ Res 1981; 48: 692–700
- Nakaya H, Schwartz A, Millard R W. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil and nifedipine compared. Circ Res 1983; 52: 302–311
- Rosow C E. Sufentanil citrate: a new opioid analgesic for use in anesthesia. Pharmacotherapy 1984; 4: 11–19
- Shah M H, Dikshit R K, Mansuri S M. The calcium channel antagonist, verapamil, potentiates the inhibitory action of morphine on intestinal and biliary motility. J Pharm Pharmacol 1987; 39: 1037–1038
- McAllister RG, Jr. Clinical pharmacokinetics of calcium channel antagonists. J Cardiovasc Pharmacol 1982; 4: S340–S345